2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$9.96-$0.010 (-0.10%)
Price as of Nov 11, 2026 7:35 PM EST- $1.7BMarket Cap
- 188.99%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$9.96-$0.010 (-0.10%)
ABSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.97 | ||
Change | -$0.83 (-7.69%) | ||
Open | $10.37 | ||
High | $10.92 | ||
Low | $9.68 | ||
Previous Close | $10.80 | ||
Volume | 4,102,932 | ||
30-Day Average Volume | 3,849,747 | ||
1-Week Change | -0.30% | ||
1-Month Change | -1.87% | ||
1-Year Change | 188.99% | ||
3-Year Change | 685.04% | ||
5-Year Change | -22.65% | ||
Fundamentals | |||
Shares Outstanding | 171.6M | ||
Total Assets | $268.9M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $318,000.00 | ||
Net Income | -$33.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$33.2M | ||
EBITDA | -$30.5M | ||
Net Working Capital | $188.7M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -53 | ||
Enterprise Value/Revenue | 5,042 | ||
P/B | 7 | ||
P/E | -47 | ||
PEG | 5 | ||
Price/Free Cash Flow | -62 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue